-
ACXP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Acurx Pharmaceuticals (ACXP)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.76 mm | 5.76 mm | 5.76 mm | 5.76 mm | 5.76 mm | |
Cash burn (monthly) | 1.05 mm | 281.94 k | 940.53 k | 1.29 mm | 779.52 k | |
Cash used (since last report) | 2.95 mm | 789.99 k | 2.64 mm | 3.60 mm | 2.18 mm | |
Cash remaining | 2.81 mm | 4.97 mm | 3.13 mm | 2.16 mm | 3.58 mm | |
Runway (months of cash) | 2.7 | 17.6 | 3.3 | 1.7 | 4.6 |
13F holders | Current |
---|---|
Total holders | 11 |
Opened positions | 4 |
Closed positions | 3 |
Increased positions | 5 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 3.89 bn |
Total shares | 1.47 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Armistice Capital | 1.18 mm | $3.13 bn |
Vanguard | 121.04 k | $320.77 mm |
Geode Capital Management | 77.28 k | $204.80 mm |
Advisor | 22.00 k | $58.30 mm |
BLK BlackRock | 18.88 k | $50.02 mm |
Millennium Management | 17.31 k | $45.87 mm |
One68 Global Capital | 13.04 k | $34.57 mm |
Tocqueville Asset Management | 10.10 k | $26.77 mm |
Tower Research Capital | 4.45 k | $11.78 mm |
RY Royal Bank of Canada | 121.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jun 24 | James J. Donohue | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 12,000 | 28.56 k | 12,000 |
17 Jun 24 | Jack H Dean | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 12,000 | 28.56 k | 12,000 |
17 Jun 24 | Carl Sailer | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 12,000 | 28.56 k | 12,000 |
17 Jun 24 | Scodari Joseph C | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 12,000 | 28.56 k | 12,000 |
17 Jun 24 | Thomas L Harrison | Stock Option Common Stock | Grant | Acquire A | No | No | 2.38 | 12,000 | 28.56 k | 12,000 |